Aniyou Labs secures 290M after leaving Bytedance

Bytedance, the parent company of TikTok, announced that it has raised $290 million for its AI-driven drug development unit, which has become independent from the parent company. The goal is to support the development of new drugs and the design of molecules more quickly and efficiently. The unit utilizes advanced technologies for target identification and compound design, with a focus on accelerating drug discovery processes while reducing costs and time. Although independent, Bytedance will still hold a 56% stake in the unit. This move is part of a broader effort to expand the applications of artificial intelligence in the life sciences sector, where the field emphasizes improving drug discovery processes using models that analyze molecular and protein data.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل